Les membres de la SFBTM ont cordialement été invités à participer au Symposium XLH qui se tiendra à Paris le 9 septembre prochain.
Voici le texte – en version originale – de l’annonce ci-dessous. Et le site correspondant est à cette adresse.
On behalf of the Organizing Committee, we have the honor and pleasure to invite you to attend the 2016 XLH Symposium (Sep 9, 2016, IMAGINE institute, Paris). The theme of this 1-day event is « X-Linked Hypophosphatemia, from birth to adulthood ».
The 2016 XLH Symposium will bring together experts and practitioners from various countries to discuss research advance on X-Linked Hypophosphatemia and current issues in the management of the disease.
The preliminary program focuses on:
- Scientific update on XLH: recent finding from animal models and human physiopathology
- Therapeutic Management
- Adult and pediatric cases
The list of confirmed speakers includes:
- Thomas Carpenter (Yale center for XLH)
- Carolyn Macica (Quinnipiac University)
- Aline Martin (Northwestern University)
- Agnes Linglart (Bicetre Hospital)
- Dirk Schnabel (Charite, Berlin)
- Federicco Di Rocco (Lyon Hospital)
- Karine Briot (Cochin Hospital)
- Martin Biosse-Duplan (Paris 5 University)
The symposium will be held on Sep 9, 2016 at IMAGINE, the recently launched institute for rare disease research, located in the heart of Paris.
This event will represent a great opportunity for International researchers and clinicians to discuss and share expertise on XLH, as well as a good opportunity to initiate new partnerships and identify new research objectives.
The symposium is free of charge. However, limited seats are available, so please confirm your attendance at: xlh-symposium-2016.rvrh.fr
We look forward to seeing you in Paris on Sep 9 !
- Agnes Linglart (Bicetre Hospital, Paris) Conference chairwoman
- Pol Harvengt Chair of the XLH- RVRH scientific committee and conference chairman
- Jerome Puravet president and the board of RVRH-XLH, the French XLH patient organisation